Skip to main content

Month: January 2025

Two New Toll Brothers Model Homes Open in Irvine, California

Prospective home buyers are invited to the grand opening event this Saturday, January 25 to tour the stunning Avelina and Vidara model homes IRVINE, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL), the nation’s leading builder of luxury homes, has announced the grand opening of two new Southern California model homes at Elevate by Toll Brothers at Great Park Neighborhoods. The professionally decorated Avelina and Vidara model homes will be unveiled during a special event on Saturday, January 25 from 11 a.m. to 2 p.m. at the Elevate by Toll Brothers community located at 105 Apron in Irvine, California. “The new Avelina and Vidara model homes showcase the exceptional design and luxury features that Toll Brothers is known for,” said Brad Hare, Division President of Toll Brothers in Southern California. “We...

Continue reading

Havila Shipping ASA: Allegation from certain banks of default of the restructuring agreement – disputed by the company.

Reference is made to the stock exchange announcement 1 October 2024, informing that three bank lenders, and the bondholders in two bond loans had decided to have their debt settled at the end of 2024 in accordance with the terms of the restructuring agreement. It was also reported that three banks chose to extend the restructuring agreement by one year related to two vessels in operation and four sold vessels. Reference is also made to the stock exchange announcement of 30 December 2024, where settlement of the debt related to Havila Borg, Havila Clipper, Havila Fanø and Havila Subsea was announced. Cash settlement of NOK 499.6 million was refinanced by a bond issue and non-interest-bearing debt of NOK 522.3 million was converted into shares.  Three banks that extended the restructuring agreement are financing the PSV vessel Havila Foresight...

Continue reading

Scilex Holding Company Announces that It Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)

PALO ALTO, Calif., Jan. 21, 2025 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that it has received notification from The Nasdaq Stock Market LLC that the Company has regained compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. For more information on Scilex Holding Company, refer to www.scilexholding.com For more information on Semnur Pharmaceuticals, Inc., refer to www.semnurpharma.com For...

Continue reading

2024 PRELIMINARY RESULTS, 2025 PRELIMINARY OUTLOOK & FINANCIAL AMBITIONS

COMPANY ANNOUNCEMENT no. 03 – 21 January 2025 2024 EBIT of DKK 1.5bn 2025 EBIT outlook of around DKK 1.0bn Financial ambitions for 2026/27 no longer applicable“Most of our business units are set to uphold performance in 2025, but we do have specific challenges to resolve in 2025 before we again can deliver a satisfactory earnings level. The main ones are an adaptation of our Mediterranean network to recent market changes and the planned financial turnaround of our new Turkish transport company”, says Torben Carlsen, CEO of DFDS.   Preliminary results for 2024     DFDS’ revenue for 2024 increased 9.0% to DKK 29.8bn which was in line with the latest outlook revenue growth range of 8-10%. The 2024 EBIT was DKK 1.5bn in line with the latest EBIT outlook range of DKK 1.5-1.7bn. The adjusted free cash flow for 2024 was DKK...

Continue reading

Alstom S.A.: Alstom’s third quarter 2024/25: confirmed outlook for FY 2024/25

  Alstom’s third quarter 2024/25: confirmed outlook for FY 2024/25    Q3 Order intake at €4.3 billion, 9 months at €15.2 billion Q3 Sales at €4.7 billion, 9 months at €13.4 billion – up 5.3% vs last year, of which 6.9% organic Fiscal year 2024/25 outlookBook-to-bill above 1 and sales organic growth around 5% aEBIT margin around 6.5% Free Cash Flow within the range €300 million to €500 million21 January 2025 – Over the third quarter of 2024/25 (from 1 October to 31 December 2024), Alstom booked €4.3 billion of orders. The Group’s sales reached €4.7 billion in the quarter and Rolling Stock production output totalled 1,098 cars. For the first nine months of 2024/25 (from 1 April to 31 December 2024), Alstom’s order intake reached €15.2 billion, compared to €13.9 billion for the same period last fiscal year. The Group sales increased...

Continue reading

Unlocking Efficiency & Reducing Loss: Kudelski IoT’s RecovR and KEYper Systems Team Up to Revolutionize Dealership Key Management in Automotive Retail

PHOENIX, AZ, CHESAUX-SUR-LAUSANNE, Switzerland, and HARRISBURG, N.C., USA, Jan. 21, 2025 (GLOBE NEWSWIRE) — Kudelski IoT, a division of the Kudelski Group (SIX: KUD.S) and a pioneer in digital security and IoT solutions, and KEYper Systems, an ASSA ABLOY company, today announced a strategic collaboration to transform key management for car dealerships. The partnership brings together the secure key storage and checkout solutions of KEYper Systems with the advanced, real-time dealershipwide key location tracking capabilities of Kudelski IoT’s RecovR for Keys. Car dealerships face significant challenges due to key mismanagement, leading to operational inefficiencies and financial losses. While specific statistics on key loss are scarce, RecovR’s customer survey indicates that dealerships lose an average of $30,000 per year due to...

Continue reading

Transgene to Participate in the Biomed Forum Investor Conference

Strasbourg (France), January 21, 2025, 5:45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the upcoming edition of the Biomed Forum, a conference for institutional investors. Organized by AllInvest Securities, this event will take place on February 4, 2025, in Paris. *** About Transgene Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing targeted immunotherapies for the treatment of cancer. Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells.The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines and oncolytic viruses: TG4050, the first individualized therapeutic...

Continue reading

Sidetrade: Outstanding 26% growth in Revenue for 2024

Solid Q4 2024: subscription bookings up 33% New record for bookings, year-over-year Strong revenue growth in 2024, up 26%, with SaaS subscriptions up 22%Consolidated expansion in Europe with the acquisition of SHS Viveon Revenue up 36% in the United States 65% of revenue in international marketsSidetrade rises to the Top 15% in EcoVadis ratings Sidetrade, the global leader in AI-powered Order-to-Cash applications, announces 26% revenue growth for the 2024 fiscal year. Olivier Novasque, CEO of Sidetrade, commented: “Following a downturn in the third quarter, we finished the year with a return to dynamic growth for fourth-quarter bookings, posting slightly more than €2 million in new annual recurring revenue (ARR), significantly up by 33% year-over-year. Except for Q3, we successfully aligned three out of four quarters throughout the...

Continue reading

Quantum and Space Technologies Take Center Stage during the EmTech Invest at Davos 2025

Geneva, Switzerland, Jan. 21, 2025 (GLOBE NEWSWIRE) — WISeSat.Space and SEALSQ Achieve Breakthrough in Post-Quantum Transactions from SpaceSEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company specializing in Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced that during this year’s World Economic Forum in Davos quantum technology and space exploration have emerged as dominant themes. Among the standout innovations garnering attention is the groundbreaking integration by WISeSat.Space and SEALSQ, enabling secure post-quantum transactions using SEALCOIN crypto tokens directly from space. This pioneering achievement sets a new benchmark in the application of quantum-resistant cryptography in satellite communications.WISeSat.Space, in collaboration...

Continue reading

Iveco Group announces Senior Leadership Team changes

Turin, 21st January 2025. Iveco Group N.V. (EXM: IVG) today announces changes to its Senior Leadership Team (SLT). Effective immediately, Domenico Nucera will assume the newly created role of Chief Quality & Operations Officer and Claudio Passerini will take over as President, Bus Business Unit. Both will report directly to Olof Persson, CEO of Iveco Group. Iveco Group’s new Quality & Operations function will regroup and centralise all Quality departments and incorporate Manufacturing and Supply Chain. Integrated Quality & Operations will connect every operational aspect of the business – from sourcing to production and delivery – enabling the Group to work even more cohesively and efficiently. The new function will be under the leadership of Domenico Nucera, who has led the Bus Business Unit of Iveco Group since its inception....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.